Literature DB >> 22025010

Organizing pneumonia associated with oxaliplatin-combined chemotherapy: a case report.

Eun Joo Lee1, Sang Yeub Lee, Kwang Ho In, Chul Hwan Kim, Sanghoon Park.   

Abstract

OBJECTIVE: To report a case of oxaliplatin-combined chemotherapy-induced interstitial lung disease. CLINICAL PRESENTATION AND INTERVENTION: A 57-year-old man was referred complaining of dyspnea and fever after treatment with an oxaliplatin-combined chemotherapeutic agent for metastatic colorectal cancer. Fever development and spontaneous subsidence were observed during the chemotherapeutic course repeatedly until the 9th cycle. A computer-tomographic (CT) scan revealed bilateral, peripherally distributed, patchy consolidation suggestive of an interstitial lung disease. As a confirmative step, video-assisted thoracoscopic surgical biopsy was attempted; the characteristic intraluminal organizing fibrous plug in the bronchioles and alveoli was seen. Corticosteroid therapy was administered, which rapidly improved the patient's symptoms and chest CT findings.
CONCLUSION: This case showed that oxaliplatin may be implicated in the etiology of interstitial lung disease, since withdrawal of the drug resulted in improvement of interstitial lung disease.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22025010     DOI: 10.1159/000331898

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  8 in total

1.  Oxaliplatin-associated sarcoid-like reaction masquerading as recurrent colon cancer.

Authors:  Surya Kiran Aedma; Anusha Chidharla; Sarah Kelting; Anup Kasi
Journal:  BMJ Case Rep       Date:  2020-09-08

2.  Oxaliplatin-Induced Pulmonary Toxicity in Gastrointestinal Malignancies: Two Case Reports and Review of the Literature.

Authors:  Mor Moskovitz; Mira Wollner; Nissim Haim
Journal:  Case Rep Oncol Med       Date:  2015-05-10

3.  Saddle pulmonary embolus and bronchiolitis obliterans with organizing pneumonia develop simultaneously after first cyclophosphamide, methotrexate, 5FU chemotherapy for breast cancer.

Authors:  Fahad M Al-Hameed
Journal:  Saudi Med J       Date:  2015-06       Impact factor: 1.484

4.  Sarcoidosis associated with oxaliplatin-based chemotherapy for colorectal cancer.

Authors:  Ji Hoon Choi; Jung A Shin; Hye Kyeong Park; Su Young Kim; Hoon Jung; Sung-Soon Lee; Hye Ran Lee; Hyeon-Kyoung Koo
Journal:  Case Rep Oncol Med       Date:  2014-03-04

5.  Pulmonary Fibrosis Secondary to FOLFOX Chemotherapy: A Case Report.

Authors:  Wai Cheong Soon; Kate West; David Gibeon; Elizabeth Frances Bowen
Journal:  Case Rep Oncol       Date:  2014-09-24

6.  Pulmonary toxicity of craniospinal irradiation using helical tomotherapy.

Authors:  Joongyo Lee; Euidam Kim; Nalee Kim; Chang-Ok Suh; Yoonsun Chung; Hong In Yoon
Journal:  Sci Rep       Date:  2022-02-25       Impact factor: 4.379

Review 7.  Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient.

Authors:  Annick De Weerdt; Amélie Dendooven; Annemie Snoeckx; Jan Pen; Martin Lammens; Philippe G Jorens
Journal:  BMC Cancer       Date:  2017-08-29       Impact factor: 4.430

8.  Evaluation of oxaliplatin-induced pulmonary toxicity in rats.

Authors:  Serdar Kalemci; Ozgür Tanrıverdi; Abdullah Şimşek; Saliha Aksun; Ozgür I Celik; Sabri Barutca; Arife Zeybek; Buket Demirci
Journal:  Contemp Oncol (Pozn)       Date:  2019-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.